- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07448233
Application of Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
This project, titled " Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 1276 patients from eight rural counties in China's northwest region. This study aims to establish a new scheme for improving epilepsy management in rural areas of Northwest China by combining remote mobile health management technology. The primary objective is to evaluate the effectiveness of the remote medical management model using a mobile health management mini-program in improving the self-management ability of rural epilepsy patients; secondary objectives include evaluating the impact of this model on patients' medication adherence, quality of life, health status, and frequency of epileptic seizures. Key components include patient and doctor interfaces for features like medication reminders, and seizure records. The trial runs from December 1, 2025, to November 30, 2028, with primary outcomes measured at 6 and12 months and secondary outcomes assessing medication adherence, quality of life, and safety.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Shaanxi
-
Xi'an, Shaanxi, Kina, 710032
- Department of Neurology, Xijing Hospital, Air Force Medical University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Patient inclusion criteria:
- Meet the diagnostic criteria for epilepsy established by the International League Against Epilepsy (ILAE).
- Participate in the national rural epilepsy prevention and management project.
- Aged 18 to 64.
- The patient or their primary caregiver possesses a smartphone and is capable of using WeChat.
- Volunteer to participate in the study and sign a written informed consent form.
Patient exclusion criteria:
- Women who plan to become pregnant, are in pregnancy, or are breastfeeding.
- The seizures are caused by clear and reversible triggers.
- Those who have achieved epilepsy remission criteria and currently do not require long-term antiepileptic drug management.
- Severe infections, malignant tumors, severe dysfunction of heart, liver, and kidney functions, or severe physical diseases that the researcher believes will significantly affect epilepsy management, outcome evaluation, or follow-up completion.
- Individuals with severe mental, cognitive, or communication impairments who are unable to cooperate with research and remote management.
- It is expected that the participant will not be able to complete the required follow-up visits, or the investigator deems the participant unsuitable for participation in this study.
- Have participated in any other clinical trials within the past 6 months.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Standard Landlig Epilepsihåndtering
|
|
|
Eksperimentel: Forbedret Administration med Mobilapp
|
Patient Module: Real-time monitoring, medication reminders, seizure logging, educational resources. Physician Module: remote follow-up, data analytics dashboard. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Epilepsy Self Management Scale Score
Tidsramme: 6 and 12 months
|
Evaluation method: The Chinese version of the Epilepsy Self Management Scale was used. This scale includes multiple dimensions (such as drug management, information management, safety management, etc.), and a higher total score indicates stronger self-management ability. |
6 and 12 months
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- XJLL-KY-20252555
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
IPD will not be shared due to privacy constraints, contractual agreements.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .